Bausch + Lomb has initiated a clinical trial of a new ophthalmic viscosurgical device, the company announced in a press release.
The OVD is intended to provide a novel formulation to meet a cataract surgeon’s needs, the release said. The company plans to file for premarket approval with the FDA at the end of the trial and bring the product to market in the U.S. in 2019.
“OVDs play a critical role in ophthalmic surgery, and selection is highly individualized based on clinical surgical requirements and the surgeon’s preferences,” Chuck (Read more...)
Uncategorized